Pangaea Oncology, S.A. (BME: PANG) Stock Analysis & Fundamentals

PANGPangaea Oncology, S.A.

BME · ES · Healthcare · Diagnostics & Research · panoncology.com

1.550EUR0.00%Mkt Cap: 58.55M $P/E: —2d ago

Pangaea Oncology, S.A., a precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries. The company offers molecular diagnostics, including mutation analys…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

IDEXX Laboratories, Inc.

$44.35BUSDP/E 39.5

Agilent Technologies, Inc.

Mettler-Toledo International, Inc.

$28.55BUSDP/E 32.1

Labcorp Holdings Inc.

$26.80BUSDP/E 27.4

DGX

Quest Diagnostics Incorporated

$26.68BUSDP/E 25.6

Guardant Health, Inc.

$21.92BUSD

MEDP

Medpace Holdings, Inc.

$16.98BUSDP/E 35.8

ERF

Eurofins Scientific SE

$13.64BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$13.84BUSD

RVTY

Revvity Inc. Common Stock

Twist Bioscience Corp.

$8.93BUSD

Key Statistics

Company

Market Cap58.55M $

Enterprise Value63.14M $

Revenue (TTM)18.19M $

Gross Profit15.67M $

Net Income (TTM)-3.91M $

Revenue/Share0.5065 USD

Last Price1.550 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees165

CountryES

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)Infinity

PEG—

EV/EBITDA-22.32

EV/Revenue3.47

P/S3.33

P/B2.61

EPS (TTM)-0.10

EPS (Forward)0.00

52W Range

1.48026% of range1.750

52W High1.750 EUR

52W Low1.480 EUR

Profitability

Gross Margin99.28%

Oper. Margin-26.07%

EBITDA Margin-15.55%

Profit Margin-24.76%

ROE-16.88%

ROA-11.20%

Growth

Revenue Growth-9.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.74M $

CapEx (TTM)513.57K $

FCF Margin-5.17%

FCF Yield-1.61%

Net Debt1.81M $

Net Debt/EBITDA-0.64

Balance Sheet

Debt/Equity0.27

Current Ratio1.78

Quick Ratio1.47

Book Value/Sh0.5930 EUR

Cash/Share0.0860 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 EUR

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.35.91M

Float10.87M

Insiders69.26%

Institutions0.34%

Technical

SMA 501.543 (+0.5%)

SMA 2001.637 (-5.3%)

Beta0.01

S&P 52W Chg18.16%

Avg Vol (30d)182

Avg Vol (10d)4

Technical Indicators

RSI (14)51.9

MACD0.0016

MACD Signal0.0003

MACD Hist.+0.0012

BB Upper1.578 EUR

BB Middle1.546 EUR

BB Lower1.515 EUR

BB Width4.05%

ATR (14)0.0102 EUR

Vol Ratio (20d)0.00x